Dr. Koletar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1581 Dodd Dr
Fl 4
Columbus, OH 43210Phone+1 614-293-4854Fax+1 614-293-4487
Education & Training
- Ohio State University HospitalFellowship, Infectious Disease, 1986 - 1988
- Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Internal Medicine, 1983 - 1986
- West Virginia University School of MedicineClass of 1983
Certifications & Licensure
- OH State Medical License 1986 - 2026
- WV State Medical License 1984 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy Start of enrollment: 1997 Oct 01
- A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
- Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 192 citationsEfficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Rand...Jeffrey L. Lennox, Raphael J. Landovitz, Heather J. Ribaudo, Ighovwerha Ofotokun, Lumine H. Na
Annals of Internal Medicine. 2014-10-07 - 238 citationsAbacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.Paul E. Sax, Camlin Tierney, Ann C. Collier, Margaret A. Fischl, Katie R. Mollan
The New England Journal of Medicine. 2009-12-16 - 24 citationsRandomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART.Sharon A. Riddler, Lu Zheng, Christine M. Durand, Justin Ritz, Richard A. Koup
Open Forum Infectious Diseases. 2018-10-01
Journal Articles
- The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with Human Immunodeficiency Virus...C William Wester, Edgar Turner Overton, Susan L Koletar, Kristine M Erlandson, Constance A Benson, Robert C Kalayjian, Clinical Infectious Diseases
Press Mentions
- What We Know About the Ohio Measles OutbreakJanuary 15th, 2023
- Infectious Diseases Society of America Announces Next Editor-in-Chief of the Journal of Infectious DiseasesJanuary 11th, 2022
- Number of Ohio COVID Cases near Same as Delta SurgeDecember 8th, 2021
- Join now to see all
Grant Support
- The Ohio State University AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
- Safety, Tolerability, And Pharmacokinetic Interactions Of AtazanavirNational Center For Research Resources2008
- Clinical Trial: HIV Treatment-Experienced Patients To Evaluate Pa103001-04National Center For Research Resources2008
- Lopinavir/Ritonavir Pharmacokinetics In HIV-1National Center For Research Resources2006–2008
- Safety, Tolerability, And Pharmacokinetic Interactions Of Atazanavir And RifampNational Center For Research Resources2006–2007
- Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2002–2006
- Randomized Multicenter Phase II Study Of Continuous Infusion ProleukinNational Center For Research Resources1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: